The AGE (advanced glycation end-products)–RAGE (receptor for AGE) system is a pro-inflammatory pathway that contributes to the pathogenesis of obesity and obesity-related cardiovascular disorders (CVD). Circulating AGE and the soluble form of RAGE (sRAGE) has been suggested as a potential biomarker of CVD related to obesity. In this study, we aim to (1) summarize the current knowledge about the role of obesity in the onset and progression of CVD, (2) discuss the role of the AGE–RAGE system as a pathway promoting obesity and linking obesity to CVD, and (3) highlight available strategies for reducing AGE–RAGE system activation and the associated beneficial effects.

The Advanced Glycation End-Products (AGE)–Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases / E. Vianello, A.P. Beltrami, A. Aleksova, M. Janjusevic, A.L. Fluca, M.M. Corsi Romanelli, L. La Sala, E. Dozio. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 26:8(2025 Apr 14), pp. 3707.1-3707.26. [10.3390/ijms26083707]

The Advanced Glycation End-Products (AGE)–Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases

E. Vianello
Primo
;
M.M. Corsi Romanelli;L. La Sala
Penultimo
;
E. Dozio
Ultimo
2025

Abstract

The AGE (advanced glycation end-products)–RAGE (receptor for AGE) system is a pro-inflammatory pathway that contributes to the pathogenesis of obesity and obesity-related cardiovascular disorders (CVD). Circulating AGE and the soluble form of RAGE (sRAGE) has been suggested as a potential biomarker of CVD related to obesity. In this study, we aim to (1) summarize the current knowledge about the role of obesity in the onset and progression of CVD, (2) discuss the role of the AGE–RAGE system as a pathway promoting obesity and linking obesity to CVD, and (3) highlight available strategies for reducing AGE–RAGE system activation and the associated beneficial effects.
advanced glycation end-products; atherosclerosis; apoptosis; adipose tissue; cardiovascular diseases; cardiovascular risk; heart failure; inflammation; obesity; oxidative stress; receptor for advanced glycation end-products
Settore MEDS-02/A - Patologia generale
Settore MEDS-08/A - Endocrinologia
Settore MEDS-26/D - Scienze tecniche mediche e chirurgiche avanzate
14-apr-2025
Article (author)
File in questo prodotto:
File Dimensione Formato  
ijms-26-03707-v2.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 1.11 MB
Formato Adobe PDF
1.11 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1173617
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
  • OpenAlex ND
social impact